RT Journal Article
SR Electronic
T1 Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001504
DO 10.1136/jitc-2020-001504
VO 9
IS 3
A1 Ricciuti, Biagio
A1 Jones, Greg
A1 Severgnini, Mariano
A1 Alessi, Joao V
A1 Recondo, Gonzalo
A1 Lawrence, Marissa
A1 Forshew, Tim
A1 Lydon, Christine
A1 Nishino, Mizuki
A1 Cheng, Michael
A1 Awad, Mark
YR 2021
UL http://jitc.bmj.com/content/9/3/e001504.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.